Global Health Ventures Name Change and Corporate Restructuring
November 08, 2011 09:17 ET
|
Global Health Ventures Inc.
VANCOUVER, British Columbia and PHOENIX, Nov. 8, 2011 (GLOBE NEWSWIRE) -- Global Health Ventures Inc. (OTCBB:GHLV), a specialty pharmaceutical company with focus on sublingual and orodispersable drugs...
Better Investing National Convention to Host Global Health Ventures Inc. CEO to Present GHLV Sublingual Drug Delivery System September 17th, 2011
September 15, 2011 13:07 ET
|
Global Health Ventures Inc.
VANCOUVER, British Columbia, Sept. 15, 2011 (GLOBE NEWSWIRE) -- Global Health Ventures Inc. (OTCBB:GHLV), a specialty pharmaceutical company with focus on sublingual drug delivery, is pleased to...
Global Health Ventures Inc. CEO's Exclusive Interview With PremierStocks.tv at The MoneyShow in San Francisco, CA of Sublingual Drug Delivery System
August 23, 2011 09:22 ET
|
Global Health Ventures Inc.
PHOENIX, Ariz. and VANCOUVER, B.C., Aug. 23, 2011 (GLOBE NEWSWIRE) -- Global Health Ventures Inc. (OTCBB:GHLV), a specialty pharmaceutical company with a focus on sublingual drug delivery, is pleased...
Global Health Ventures Initiates Development of Sublingual NSAIDs
July 12, 2011 09:14 ET
|
Global Health Ventures Inc.
VANCOUVER, British Columbia, July 12, 2011 (GLOBE NEWSWIRE) -- Global Health Ventures Inc. (OTCBB:GHLV), a specialty pharmaceutical company with focus on sublingual drug delivery, is pleased to...
Global Health Ventures Appoints New Senior Vice President and Chief Operating Officer
July 06, 2011 09:19 ET
|
Global Health Ventures Inc.
VANCOUVER, British Columbia, July 6, 2011 (GLOBE NEWSWIRE) -- Global Health Ventures Inc. (OTCBB:GHLV), a specialty pharmaceutical company with focus on sublingual drug delivery, is pleased to...
Global Health Ventures Completes European Clinical Trials Phase I for X-Excite vs. Viagra(R)
June 22, 2011 09:17 ET
|
Global Health Ventures Inc.
VANCOUVER, British Columbia, June 22, 2011 (GLOBE NEWSWIRE) -- Global Health Ventures Inc. (OTCBB:GHLV), a specialty pharmaceutical company with focus on sublingual drug delivery is pleased to...
Global Health Ventures Engages FDA Approved Contract Manufacturing Company for the Production of X-Excite
June 02, 2011 09:12 ET
|
Global Health Ventures Inc.
VANCOUVER, British Columbia, June 2, 2011 (GLOBE NEWSWIRE) -- Global Health Ventures Inc. (OTCBB:GHLV), a specialty pharmaceutical company with focus on sublingual drug delivery is pleased to announce...
Global Health Ventures to Initiate Discussion With Omnicare on X-Excite vs. Viagra(R) Trials in the United States
April 27, 2011 08:56 ET
|
Global Health Ventures Inc.
VANCOUVER, British Columbia, April 27, 2011 (GLOBE NEWSWIRE) -- Global Health Ventures Inc. (OTCBB:GHLV), a specialty pharmaceutical company, is pleased to announce that it has started discussions for...
Global Health Ventures Completes X-Excite Formulation for North American Clinical Trials
April 12, 2011 08:56 ET
|
Global Health Ventures Inc.
VANCOUVER, British Columbia, April 12, 2011 (GLOBE NEWSWIRE) -- Global Health Ventures Inc. (OTCBB:GHLV) a specialty pharmaceutical company is pleased to announce that has completed the final...
Global Health Ventures Announces Interim Data From the European Clinical Trails of X-Excite vs. Viagra
March 30, 2011 09:12 ET
|
Global Health Ventures Inc.
VANCOUVER, British Columbia, March 30, 2011 (GLOBE NEWSWIRE) -- Global Health Ventures Inc. (OTCBB:GHLV), a specialty pharmaceutical company, is pleased to announce the interim results of the clinical...